The text starts here.

News Release

May 21, 1998

Eisai Announces Proposal for Partial Amendment to the Articles of Incorporation to Enable Purchases of Eisai Stock

Tokyo (May 21, 1998) - Eisai Co., Ltd. of Tokyo (President and CEO: Haruo Naito) announced that at the Board of Directors Meeting on May 21,1998, approval was received regarding a proposal to partially amend the articles of incorporation to enable the purchase of Eisai stock that will be recommended for adoption at the 86th Ordinary General Meeting of Shareholders (scheduled for June 26, 1998). This proposal is in accordance with the provisions of Article 3 of the Law for Special Exceptions to the Commercial Code concerning Procedure of Cancellation of Shares.

Listed Name on Stock Exchange(s): Eisai Company, Ltd.
Head Office Address: 4-6-10 Koishikawa,Bunkyo-ku,Tokyo
Stock Code Number: 4523
Stock Listing Location(s): Tokyo & Osaka 1st Section
Board Member / General Affairs Director: Tai Shimizu
Contact Phone Number: (03) 3817-5030
  1. Type of Stock Authorized for Purchase Common Stock
  2. Stock Purchase Limitation 29,000,000 shares

Eisai Co., Ltd. is a research-based human health care company which discovers, develops and markets products in more than 30 countries. Through its global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. The company reported sales of about $2.3 billion in 1997 with approximately 16 percent of sales spent for research and development.